Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.

Source:http://linkedlifedata.com/resource/pubmed/id/16149905

Download in:

View as

General Info

PMID
16149905